Institution · EuroQol Research Foundation
Most cited papers from EuroQol Research Foundation
What are the most cited papers from EuroQol Research Foundation?
The most cited paper from EuroQol Research Foundation is "Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)" (Michael Herdman, Claire M. Gudex, Andrew J. Lloyd et al., 2011), with 10,323 citations. Next come "Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets" (2,251) and "EQ-5D and the EuroQol Group: Past, Present and Future" (1,242).
Showing 50 of 61 papers. Every paper with more than 43 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) Michael Herdman, Claire M. Gudex, Andrew J. Lloyd et al. · Quality of Life Research | 8 Apr 2011 | 10,323 |
| 2 | Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets Ben van Hout, Mathieu F. Janssen, You‐Shan Feng et al. · Value in Health | 24 May 2012 | 2,251 |
| 3 | EQ-5D and the EuroQol Group: Past, Present and Future Nancy J. Devlin, Richard G. Brooks · Applied Health Economics and Health Policy | 13 Feb 2017 | 1,242 |
| 4 | Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021 Global Burden of Disease Long COVID Collaborators et al. · JAMA | 10 Oct 2022 | 939 |
| 5 | A comparison of the EQ‐5D and SF‐6D across seven patient groups John Brazier, Jennifer Roberts, Aki Tsuchiya et al. · Health Economics | 9 Jan 2004 | 810 |
| 6 | The frequency of lysosomal storage diseases in The Netherlands Ben J. H. M. Poorthuis, Ron A. Wevers, Wim J. Kleijer et al. · Human Genetics | Aug 1999 | 728 |
| 7 | A Program of Methodological Research to Arrive at the New International EQ-5D-5L Valuation Protocol Mark Oppe, Nancy J. Devlin, Ben van Hout et al. · Value in Health | Jun 2014 | 440 |
| 8 | Overview, Update, and Lessons Learned From the International EQ-5D-5L Valuation Work: Version 2 of the EQ-5D-5L Valuation Protocol Elly A. Stolk, Kristina Ludwig, Kim Rand et al. · Value in Health | 2019 | 369 |
| 9 | Population norms for the EQ-5D-3L: a cross-country analysis of population surveys for 20 countries Mathieu F. Janssen, Ágota Szende, J. Cabases et al. · The European Journal of Health Economics | 14 Feb 2018 | 354 |
| 10 | Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines Matthew Kennedy-Martin, Bernhard Slaap, Michael J. Herdman et al. · The European Journal of Health Economics | 8 Jun 2020 | 312 |
| 11 | Population Norms for the EQ-5D Bas Janssen, Ágota Szende | 26 Sep 2013 | 259 |
| 12 | EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes Mark Oppe, Kim Rand, Koonal Kirit Shah et al. · PharmacoEconomics | 15 Apr 2016 | 250 |
| 13 | Handling Data Quality Issues to Estimate the Spanish EQ-5D-5L Value Set Using a Hybrid Interval Regression Approach Juan Manuel Ramos-Goñi, Benjamin Matthew Craig, Mark Oppe et al. · Value in Health | 2 Dec 2017 | 249 |
| 14 | US population norms for the EQ-5D-5L and comparison of norms from face-to-face and online samples Ruixuan Jiang, Mathieu F. Janssen, Alan Simon Pickard · Quality of Life Research | 6 Oct 2020 | 237 |
| 15 | The EQ-5D-5L Valuation study in Thailand Juntana Pattanaphesaj, Montarat Thavorncharoensap, Juan Manuel Ramos-Goñi et al. · Expert Review of Pharmacoeconomics & Outcomes Research | 30 Jun 2018 | 209 |
| 16 | The Indonesian EQ-5D-5L Value Set Fredrick Dermawan Purba, Joke A. M. Hunfeld, Aulia Iskandarsyah et al. · PharmacoEconomics | 10 Jul 2017 | 208 |
| 17 | Self-Reported Population Health: An International Perspective Based on EQ-5D Ágota Szende, M.B. Janssen, J.M. Cabasés et al. · Value in Health | 22 Oct 2013 | 197 |
| 18 | Quality Control Process for EQ-5D-5L Valuation Studies Juan Manuel Ramos-Goñi, Mark Oppe, Bernhard Slaap et al. · Value in Health | 22 Dec 2016 | 180 |
| 19 | The use of the EQ-5D preference-based health status measure in adults with Type 2 diabetes mellitus Mathieu F. Janssen, Erica Ilene Lubetkin, Jackson P. Sekhobo et al. · Diabetic Medicine | 27 Sep 2010 | 176 |
| 20 | A French Value Set for the EQ-5D-5L Luiz Flavio Andrade, Kristina Ludwig, Juan Manuel Ramos Goñi et al. · PharmacoEconomics | 8 Jan 2020 | 170 |
| 21 | International Valuation Protocol for the EQ-5D-Y-3L Juan Manuel Ramos-Goñi, Mark Oppe, Elly A. Stolk et al. · PharmacoEconomics | 16 Apr 2020 | 162 |
| 22 | Valuation and Modeling of EQ-5D-5L Health States Using a Hybrid Approach Juan Manuel Ramos-Goñi, José Luis Pinto Prades, Mark Oppe et al. · Medical Care | 15 Jan 2015 | 154 |
| 23 | Assessing the Use of a Feedback Module to Model EQ-5D-5L Health States Values in Hong Kong Eliza Lai‐Yi Wong, Juan Manuel Ramos-Goñi, Annie Wai Ling Cheung et al. · Patient | 10 Oct 2017 | 146 |
| 24 | Development of an EQ-5D Value Set for India Using an Extended Design (DEVINE) Study: The Indian 5-Level Version EQ-5D Value Set Gaurav Jyani, Atul Sharma, Shankar Prinja et al. · Value in Health | 5 Jan 2022 | 137 |
| 25 | Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L Anna P. Hobbins, Luke E. Barry, Dan P. Kelleher et al. · PharmacoEconomics | 26 Jul 2018 | 136 |
| 26 | The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration Stavros Petrou, Oliver Rivero‐Arias, Helen Dakin et al. · PharmacoEconomics | 31 Jul 2015 | 128 |
| 27 | Phospholipid transfer protein Arie van Tol · Current Opinion in Lipidology | Apr 2002 | 128 |
| 28 | Developing the Chinese version of the new 5-level EQ-5D descriptive system: the response scaling approach Nan Luo, Minghui Li, Gordon G. Liu et al. · Quality of Life Research | 23 May 2012 | 128 |
| 29 | Do Productivity Costs Matter? Marieke Krol, Jocé Papenburg, Marc A. Koopmanschap et al. · PharmacoEconomics | 6 May 2011 | 127 |
| 30 | The use of patient-reported outcome measures to improve patient-related outcomes – a systematic review Joshua M. Bonsel, Ademola Joshua Itiola, Anouk Sjoukje Huberts et al. · Health and Quality of Life Outcomes | 26 Nov 2024 | 117 |
| 31 | Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective Simone Kreimeier, Mark Oppe, Juan Manuel Ramos-Goñi et al. · Value in Health | 8 Aug 2018 | 115 |
| 32 | Attribute level overlap (and color coding) can reduce task complexity, improve choice consistency, and decrease the dropout rate in discrete choice experiments Marcel F. Jonker, Bas Donkers, Esther Wilhelmina de Bekker-Grob et al. · Health Economics | 18 Dec 2018 | 112 |
| 33 | EQ-5D: a plea for accurate nomenclature Richard G. Brooks, Kristina Secnik Boye, Bernhard Slaap · Journal of Patient-Reported Outcomes | 3 Jul 2020 | 109 |
| 34 | An EQ-5D-5L value set based on Uruguayan population preferences Federico Augustovski, Lucila Rey‐Ares, Vilma Edith Irazola et al. · Quality of Life Research | 4 Aug 2015 | 102 |
| 35 | Valuing Health State: An EQ-5D-5L Value Set for Ethiopians Abraham Gebregziabiher Welie, Gebremedhin Beedemariam Gebretekle, Elly A. Stolk et al. · Value in Health Regional Issues | 3 Nov 2019 | 101 |
| 36 | An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administration Aureliano Paolo Finch, Michela Meregaglia, Oriana Ciani et al. · Social Science & Medicine | 28 Oct 2021 | 94 |
| 37 | A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021 Sarah Wulf Hanson et al. · medRxiv | 27 May 2022 | 87 |
| 38 | The impact of vaccination and patient characteristics on influenza vaccination uptake of elderly people: A discrete choice experiment Esther Wilhelmina de Bekker-Grob, Jorien Veldwijk, Marcel F. Jonker et al. · Vaccine | 6 Feb 2018 | 85 |
| 39 | Quantification of the level descriptors for the standard EQ-5D three-level system and a five-level version according to two methods Mathieu F. Janssen, Erwin Birnie, Gouke J. Bonsel · Quality of Life Research | 4 Mar 2008 | 85 |
| 40 | Valuation Survey of EQ-5D-Y Based on the International Common Protocol: Development of a Value Set in Japan Takeru Shiroiwa, Shunya Ikeda, Shinichi Noto et al. · Medical Decision Making | 23 Mar 2021 | 79 |
| 41 | A US Population Health Survey on the Impact of COVID-19 Using the EQ-5D-5L Joel W. Hay, Cynthia L. Gong, Xiayu Jiao et al. · Journal of General Internal Medicine | 8 Mar 2021 | 78 |
| 42 | An Introduction to EQ-5D Instruments and Their Applications Nancy J. Devlin, David William Parkin, Bas Janssen | 2020 | 76 |
| 43 | Effect of Level Overlap and Color Coding on Attribute Non-Attendance in Discrete Choice Experiments Marcel F. Jonker, Bas Donkers, Esther Wilhelmina de Bekker-Grob et al. · Value in Health | 20 Nov 2017 | 76 |
| 44 | Valuation of the EQ-5D-5L in Taiwan Hsiang-Wen Lin, Chia-Ing Li, Fang‐Ju Lin et al. · PLoS ONE | 26 Dec 2018 | 72 |
| 45 | A multi-level approach for the use of routinely collected patient-reported outcome measures (PROMs) data in healthcare systems Fatima Al Sayah, Markus Lahtinen, Gouke J. Bonsel et al. · Journal of Patient-Reported Outcomes | Oct 2021 | 66 |
| 46 | Health-related quality of life and mental well-being of healthy and diseased persons in 8 countries: Does stringency of government response against early COVID-19 matter? Di Long, Juanita A. Haagsma, Mathieu F. Janssen et al. · SSM - Population Health | Sep 2021 | 66 |
| 47 | ABCC6/MRP6 mutations: further insight into the molecular pathology of pseudoxanthoma elasticum Xiaofeng Hu, Astrid S. Plomp, Jan Wijnholds et al. · European Journal of Human Genetics | Mar 2003 | 62 |
| 48 | Comparing measurement properties of EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients Titi Sahidah Fitriana, Fredrick Dermawan Purba, Rina Rahmatika et al. · Health and Quality of Life Outcomes | 15 Nov 2021 | 61 |
| 49 | Advocating a Paradigm Shift in Health-State Valuations: The Estimation of Time-Preference Corrected QALY Tariffs Marcel F. Jonker, Bas Donkers, Esther Wilhelmina de Bekker-Grob et al. · Value in Health | 21 Mar 2018 | 60 |
| 50 | The remarkably frequent use of EQ-5D in non-economic research Aimin Wang, Kim Rand, Zhihao Yang et al. · The European Journal of Health Economics | 30 Nov 2021 | 59 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.